---
title: PD-1/PD-L1 Combination Therapy in Cancer Treatment
description: Download this whitepaper to learn more about blockade therapy resistance and combination therapy with CTLA-4 blockers.
image: https://go.technologynetworks.com/hubfs/Technology%20Networks/TN%20Editorial%20Calendar/Article/Sino%20Biological%20-%20Article%20Sponsorship/2022/June/smartmockups_l4injsau.png
---

![TN_Stacked_White](https://go.technologynetworks.com/hubfs/Technology%20Networks/Logos/TN_Stacked_White.png "TN_Stacked_White")

![TN_Stacked_White](https://go.technologynetworks.com/hubfs/Technology%20Networks/Logos/TN_Stacked_White.png "TN_Stacked_White")

![TN_Stacked_White-1](https://go.technologynetworks.com/hubfs/Imported%20images/TN_Stacked_White-1.png "TN_Stacked_White-1")

Whitepaper

# PD-1/PD-L1 Combination Therapy in Cancer Treatment

Cancer immunotherapy, especially the use of immune checkpoint inhibitors, has been successful in improving the treatment landscape of malignancies.

Programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) blockade therapy is a new class of anticancer immunotherapy that utilizes the body’s immune system to resist cancer and causes cancer cell death by blocking the PD-1/PD-L1 signaling pathway.

Download this whitepaper to learn more about PD-1/PD-L1:

- Blockade therapy resistance
- Combination therapy with CTLA-4 blockers
- Combination therapy with targeted drug EGFR

**Brought to you by:**

 

**![217-60 (002)](https://go.technologynetworks.com/hs-fs/hubfs/217-60%20(002).png?width=182&name=217-60%20(002).png)**

 

**Download this whitepaper to learn more about PD-1/PD-L1:**

- Blockade therapy resistance
- Combination therapy with CTLA-4 blockers
- Combination therapy with targeted drug EGFR

Download this Whitepaper for FREE Now!

![TN_Stacked](https://go.technologynetworks.com/hubfs/Imported%20images/TN_Stacked.svg "TN_Stacked")

Technology Networks Limited   
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK   
Email: privacy@technologynetworks.com   
© 2022 Technology Networks. All rights reserved

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our [Privacy Policy](https://www.technologynetworks.com/tn/privacy)

This content is copyright protected. Any public or private use of this content is subject to prevailing copyright laws. Please contact [Technology Networks](https://www.technologynetworks.com/tn/copyright) for permission requests.